市場調查報告書
商品編碼
1453944
至 2030 年醫用服裝市場預測 - 各產品、用途、配銷通路、應用、最終用戶和地理位置的全球分析Medical Clothing Market Forecasts to 2030 - Global Analysis By Product, Usage, Distribution Channel, Application, End User and by Geography |
根據 Stratistics MRC 的數據,2023 年全球醫用服裝市場規模為 1,071.2 億美元,預計到 2030 年將達到 2,100.7 億美元,預測期內複合CAGR為 10.1%。醫用服裝的使用極大地改善了清潔、安全和無菌的醫療環境。醫用服裝在製作時考慮了功能性和準確性。它包括各種衣服,如手術服、實驗室外套、手術服和防護服。這些衣服的製作符合嚴格的衛生準則,可防止雜質並減少感染傳播的機會。
世界衛生組織(WHO)表示,正確使用個人防護裝備,包括口罩和防護服等醫用服裝,對於保護醫護人員和防止傳染病在醫療機構中傳播至關重要。
提高對醫療保健相關感染 (HAI) 的了解
人們對醫療保健相關感染 (HAI) 的認知不斷增強,這是推動醫用服裝產業發展的關鍵因素。隨著人們對感染控制和預防的日益關注,醫療保健從業者和機構正在認知到專業醫用服裝在降低交叉污染風險和維持無菌醫療環境方面的重要性。此外,這種意識導致了對用於減少醫療機構感染傳播的優質防護服的需求增加。
永續性和環境議題
醫用服裝市場的一個新的限制因素是環境永續意識的不斷增強。傳統醫用服裝生產中使用的材料和製造技術可能會加劇環境退化。該行業面臨實施更環保的生產技術和環保紡織品的壓力。此外,製造商在兼顧醫用服裝的需求和環保實踐方面面臨課題,解決這些問題對於市場的長期生存至關重要。
智慧紡織品技術進步
由於智慧紡織品的不斷進步,醫用服裝市場可望大幅成長。當醫用服裝融入感測器、溫度調節紡織品和監控設備等技術時,可以更好地發揮作用。智慧紡織品使即時健康監測成為可能,這可以改善患者護理並為醫療專業人員提供有用的資訊。此外,科技和醫療服裝的融合為創新和市場成長提供了新的機會。
全球供應鏈劇變
全球供應鏈中斷可能由流行病、自然災害和地緣政治動盪等多種因素引起,對醫療服裝市場構成威脅。供應鏈中斷可能導致製造成本上升、生產延誤和原料短缺。此外,對於醫用服裝行業的公司來說,建立強大的供應鏈和多樣化的採購策略至關重要,以減少潛在的干擾並保持基本材料的持續供應。
醫療服飾市場受到 COVID-19 大流行的嚴重影響。由於保護公眾和醫護人員的個人防護裝備(PPE)需求的成長,該市場以前所未有的速度成長。對感染控制實踐的認知促使手套、防護服和口罩等醫用服裝的製造和使用顯著增加。此外,由於供應鏈中斷、原料價格波動和嚴格的監管,製造商面臨營運課題。
預計在預測期內,手術單、手術服和手術服區隔市場將是最大的
在醫用服裝市場,手術單、手術服和手術服佔據最大的市場。手術服和長袍是醫護人員重要的防護服,手術巾在手術過程中創造了一個無菌區域,以防止污染。該區隔市場的主導地位是由手術干預的持續需求、全球對感染控制方案的關注以及醫療機構進行的手術數量不斷增加所推動的。
家庭護理設定領域預計在預測期內複合CAGR最高
醫用服飾市場中的居家照護環境部分正以最高的CAGR成長。由於家庭醫療保健服務的趨勢不斷成長,用於家庭護理環境的醫用服裝的需求量很大。隨著越來越多的患者在舒適的家中接受醫療護理,專用服裝(例如患者服裝和護理人員的防護裝備)變得越來越必要。此外,對個人化醫療保健的需求、遠距醫療的進步和人口老化是轉向家庭照護的主要驅動力。
預計全球醫用服裝市場將在北美佔據最大佔有率。強力的法規、強力的監管框架、完善的醫療保健系統以及對感染控制實踐的高度認知都被認為是該地區佔據主導地位的因素。此外,北美地區積極採用醫用紡織品新技術和創新,以及對醫護人員安全的日益關注,鞏固了北美作為醫用服裝市場成長主要力量的記錄。
醫療服裝市場預計將以亞太地區最高的CAGR成長。該地區不斷變化的醫療環境推動了對醫用服裝的需求,其特點是人口不斷成長、醫療成本不斷上升以及感染控制措施意識不斷增強。此外,亞太地區的強勁成長是由多種因素造成的,包括該地區醫療基礎設施的發展,特別是在中國和印度等國家,外科手術的增加以及對衛生標準的日益重視。
2023 年 8 月,杜邦宣布達成最終協議,將 Delrin(R) 乙縮醛均聚物 (H-POM) 業務 1 的 80.1% 所有權出售給 TJC LP (TJC),交易估值為 18 億美元。 TJC 已獲得與該交易相關的全額承諾融資,預計將於 2023 年底左右完成,但須滿足慣例成交條件和監管機構批准。
2023 年5 月,全球最大的為診所牙科和醫療從業人員提供醫療保健產品和服務的供應商Henry Schein, Inc. 宣布達成協議,收購巴西領先的牙種植體製造商之一SIN Implant System,目前正在等待監管部門批准。 Henry Schein 將從 Southern Cross Group 收購 SIN,Southern Cross Group 是專注於拉丁美洲的最大獨立私募股權基金管理公司之一。該交易尚需獲得巴西經濟防禦行政委員會的批准,預計將於 2023 年下半年完成。
2023 年 5 月,3M 宣布已達成協議,將總部位於德國塞費爾德的牙科局部麻醉劑產品組合相關的某些資產出售給全球製藥行業服務提供商 Pierrel SpA(“Pierrel”),以換取收購價格為7000 萬美元,可能會根據交割和其他調整情況進行調整。
According to Stratistics MRC, the Global Medical Clothing Market is accounted for $107.12 billion in 2023 and is expected to reach $210.07 billion by 2030 growing at a CAGR of 10.1% during the forecast period. A clean, safe, and sterile healthcare environment is greatly enhanced by the use of medical clothing. Medical clothing is made with function and accuracy in mind. It includes a variety of clothes like scrubs, lab coats, surgical gowns, and protective coverings. These clothes are made to adhere to strict hygienic guidelines, offering protection from impurities and reducing the chance of infection spreading.
According to the World Health Organization (WHO), proper utilization of personal protective equipment, including medical clothing such as masks and gowns, is paramount to safeguarding healthcare workers and preventing the spread of infectious diseases in healthcare settings.
Raising knowledge of infections associated with healthcare (HAIs)
The growing consciousness regarding healthcare-associated infections (HAIs) is a key factor propelling the medical apparel industry. Healthcare practitioners and institutions are realizing the importance of specialized medical clothing in lowering the risk of cross-contamination and maintaining a sterile healthcare environment as there is a growing focus on infection control and prevention. Furthermore, the increased demand for premium, protective clothing made to reduce the spread of infections in healthcare settings is a result of this awareness.
Sustainability and environmental issues
One emerging constraint in the medical clothing market is the growing consciousness of environmental sustainability. The materials and manufacturing techniques used in traditional medical apparel production may exacerbate environmental degradation. The industry is under pressure to implement more environmentally friendly production techniques and eco-friendly textiles. Additionally, manufacturers face a challenge in juggling the demands of medical apparel with environmentally friendly practices, and resolving these issues is essential to the market's long-term viability.
Technological progress in smart textiles
The medical clothing market is poised for substantial growth due to the continuous progress in smart textiles. Medical apparel can function better when it incorporates technology, such as sensors, temperature-regulating textiles, and monitoring equipment. Real-time health monitoring is made possible by smart textiles, which could improve patient care and give medical professionals useful information. Moreover, the convergence of technology and medical apparel presents novel opportunities for innovation and market growth.
Worldwide supply chain upheavals
Global supply chain disruptions, which can be brought on by a number of things, including pandemics, natural disasters, and geopolitical unrest, pose a threat to the medical apparel market. Supply chain disruptions can result in higher manufacturing costs, production delays, and shortages of raw materials. Additionally, establishing robust supply chains and diversifying sourcing strategies are imperative for companies operating in the medical clothing sector to mitigate potential disruptions and maintain a consistent supply of essential materials.
The market for medical apparel has been significantly impacted by the COVID-19 pandemic. The market has grown at an unprecedented rate due to the rise in demand for personal protective equipment (PPE) to protect the public and healthcare workers. Awareness of infection control practices has resulted in a significant increase in the manufacture and use of medical apparel, such as gloves, gowns, and masks. Furthermore, manufacturers have faced operational challenges due to supply chain disruptions, volatile raw material prices, and strict regulations.
The Surgical Drapes, Scrubs and Gowns segment is expected to be the largest during the forecast period
In the medical clothing market, surgical drapes, scrubs, and gowns hold the largest market share. Scrubs and gowns are vital protective apparel for medical personnel, and surgical drapes create a sterile field during procedures to prevent contamination. This market segment's dominance is driven by the constant need for surgical interventions, the worldwide focus on infection control protocols, and the rising number of surgeries performed in healthcare facilities.
The Home Care Settings segment is expected to have the highest CAGR during the forecast period
The home care settings segment in the medical clothing market is growing at the highest CAGR. Medical apparel intended for use in home care settings is in high demand due to the growing trend toward home healthcare services. Specialized clothing, such as patient apparel and protective gear for caregivers, is becoming more and more necessary as more patients receive medical care in the comfort of their own homes. Additionally, the need for individualized healthcare, telemedicine advancements, and the aging population are the main drivers of the shift towards home care.
The market for medical clothing worldwide is anticipated to hold the largest share in North America. Strong regulations, a strong regulatory framework, a well-established healthcare system, and a high level of awareness of infection control practices are all considered contributing factors to the region's dominance. Furthermore, North America's record of being a major force behind the growth of the medical clothing market is cemented by the region's aggressive embrace of new technologies and innovations in medical textiles, as well as the growing focus on the safety of healthcare workers.
The medical clothing market is expected to grow at the highest CAGR in the Asia-Pacific region. The need for medical clothes is being driven by the region's changing healthcare environment, which is characterized by a growing population, rising healthcare costs, and growing awareness of infection control measures. Moreover, the strong growth in Asia-Pacific is caused by a number of factors, including the development of the region's healthcare infrastructure, especially in nations like China and India, the rise in surgical operations, and the increased emphasis on hygienic standards.
Key players in the market
Some of the key players in Medical Clothing market include DuPont de Nemours Inc., B. Braun Melsungen AG, Henry Schein, Inc., 3M Company, Smith+Nephew, Carhartt, Inc, Medline Industries, Inc., Barco Uniforms, Johnson & Johnson, Molnlycke Health Care AB, Ansell Healthcare LLC, Owens & Minor, Inc., Semperit AG Holding, Cardinal Health, Inc., Stryker Corporation, LynkTrac Technologies LLC, Narang Medical Limited and Halyard Health.
In August 2023, DuPont announced a definitive agreement to sell an 80.1% ownership interest in the Delrin(R) acetal homopolymer (H-POM) business1 to TJC LP (TJC) in a transaction valuing the business at $1.8 billion. TJC has received fully committed financing in connection with the transaction, which is expected to close around year-end 2023, subject to customary closing conditions and regulatory approval.
In May 2023, Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental and medical practitioners, announced an agreement to acquire S.I.N. Implant System, one of Brazil's leading manufacturers of dental implants, pending regulatory approval. Henry Schein will acquire S.I.N. from the Southern Cross Group, one of the largest independent private equity fund managers focused on Latin America. The transaction is subject to approval by Brazil's Administrative Council for Economic Defense and is expected to close in the latter half of 2023.
In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.